Category Archives: About GHI

GWAS 3.0

      Andreas Scherer    February 7, 2017    No Comments on GWAS 3.0
GWAS eBook

Genome-wide association study (GWAS) technology has been a primary method for identifying the genes responsible for diseases and other traits for the past ten years. GWAS continues to be highly relevant as a scientific method. Over 2000 human GWAS reports now appear in scientific journals. In fact, we see its adoption increasing beyond the human-centric research into the world of… Read more »

Golden Helix Among 50 Fastest Growing TECH Companies

Silicon Review

Golden Helix Named Among the 50 Fastest Growing TECH Companies for 2016! Golden Helix closed out 2016 with a great honor! In December, The Silicon Review magazine released a special addition in which it named Golden Helix as one of the fastest growing technology companies for 2016. You can read the interview with our CEO, Andreas Scherer here: Delivering industry-leading analytic software… Read more »

NGS-based Clinical Testing (Part III)

DNA sequencing

Getting the NGS wet bench process right is not a small undertaking. Targeted NGS assays such as multigene panels or exome sequencing allow for the targeted analysis of genomic regions that are of particular interest. For every sample type, e.g. blood, formalin-fixed paraffin-embedded specimens, saliva etc, there must be a detailed protocol in place outlining how each sample type is going… Read more »

NGS-based Clinical Testing (Part II)

ngs-based clinical testing

We have come a long way since next-generation sequencing (NGS) evolved as a set of technologies in the 1970s. The higher throughput and rapid reduction of costs associated with NGS have lead to the accelerated adoption of clinical testing that we are experiencing today. Currently, it is applied to analyze inherited diseases, tumors, hematologic malignancies and infectious diseases. It is also… Read more »